Anzeige
Mehr »
Freitag, 31.10.2025 - Börsentäglich über 12.000 News
Attestation ist die Killer-App - Republic baut sie jetzt!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JQXP | ISIN: IL0011429839 | Ticker-Symbol: 5DT
Frankfurt
31.10.25 | 08:05
2,375 Euro
+4,17 % +0,095
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
ENTERA BIO LTD Chart 1 Jahr
5-Tage-Chart
ENTERA BIO LTD 5-Tage-Chart
RealtimeGeldBriefZeit
2,4002,48518:02
2,3952,49018:02

Aktuelle News zur ENTERA BIO Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
23.10.Entera Bio reports positive data for oral osteoporosis treatment2
23.10.Entera Bio Presents Positive New Clinical Data from EB613 Phase 2 Trial Demonstrating Significant Bone Density Improvements in Early Postmenopausal Women353Consistency of BMD gains presented at NAMS 2025 demonstrate EB613's efficacy in both young postmenopausal women and in women 10 years post-menopause Data further support EB613 potential as a first-in-class...
► Artikel lesen
ENTERA BIO Aktie jetzt für 0€ handeln
16.10.Entera Bio to Present New Clinical Data from Phase 2 Trial of EB613 at the 2025 North American Menopause Society (NAMS) Annual Meeting2
25.09.Entera Bio stock rating reiterated at Buy by H.C. Wainwright2
18.09.Entera Bio Unveils Promising PK Data for First Oral GLP-2 Therapy1
15.09.Entera Bio presents promising data for oral GLP-2 treatment for SBS3
11.09.Kudelski Group: NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace340Kudelski Group / Key word(s): Miscellaneous NAGRAVISION Launches OpenTV® ENTera, the Next-Generation Digital Services Solution, in AWS Marketplace 11.09.2025 / 07:00 CET/CEST New...
► Artikel lesen
10.09.Kudelski Group: NAGRAVISION Extends OneTV Solution at ONE Hungary, powered by OpenTV® ENTera to enable Third-Party Service Bundling with the Digital Vending Machine® from Bango348Kudelski Group / Key word(s): Miscellaneous NAGRAVISION Extends OneTV Solution at ONE Hungary, powered by OpenTV® ENTera to enable Third-Party Service Bundling with the Digital...
► Artikel lesen
08.09.Entera Bio Ltd.: Entera Bio Presents Positive Effects of EB613 on Both Trabecular and Cortical Bone in Postmenopausal Women with Osteoporosis at ASBMR 20251
11.08.Entera Bio GAAP EPS of -$0.06 beats by $0.103
08.08.Entera Bio Ltd. - 10-Q, Quarterly Report1
08.08.Entera Bio Ltd.: Entera Bio Announces Second Quarter 2025 Financial Results and Business Updates177FDA provides pivotal agreement on EB613 Phase 3 design, confirming Bone Mineral Density (BMD) as primary endpoint and clearing streamlined pathway for first oral anabolic osteoporosis treatmentSignificant...
► Artikel lesen
28.07.Entera Bio stock surges after FDA agrees on BMD endpoint for EB6131
28.07.Entera Bio: Aktie legt nach positivem FDA-Bescheid für Osteoporose-Studie deutlich zu5
28.07.FDA agrees to BMD endpoint for Entera's oral osteoporosis drug1
28.07.Entera Bio Ltd.: Entera Bio Receives FDA Agreement on BMD as Primary Endpoint for EB613 Registrational, Phase 3 Study in Post-Menopausal Women with Osteoporosis259JERUSALEM, July 28, 2025 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and protein replacement therapies, announced today that in a written response...
► Artikel lesen
28.07.Entera Bio Ltd. - 8-K, Current Report1
23.07.OPKO Health's (OPK) Oral GLP-2 Analog Selected for a Poster Presentation in Collaboration with Entera Bio (ENTX)5
18.07.Entera Bio: Aktionäre genehmigen Vorstandswahl und Vergütungsvorschläge1
18.07.Entera Bio Ltd. - 8-K, Current Report1
Weiter >>
32 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1